The proportion of IDS-C@ responders ( @ % decrease from baseline ) was significantly higher for the @-mg armodafinil group versus placebo at final visit ( @ % -LSB- @/@ -RSB- vs @ % -LSB- @/@ -RSB- ; P = @ ) .